91975 ⎘
Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings; Saturated polycyclic compounds having a carboxyl group bound to a condensed ring system having three rings
SALTS AND CRYSTALLINE FORMS OF A PD-1/PD-L1 INHIBITOR
#2Resist composition and pattern forming process
#3Method for preparing 3(4),8(9)-bisformyltricyclo[5.2.1.0]decane
#4Salts and crystalline forms of a PD-1/PD-L1 inhibitor
#5Resist composition and patterning process
#6MULTIPLE-COMPONENT SOLID PHASES CONTAINING AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT
#7Adamantane-intercalated layered double hydroxide
#8MULTIPLE-COMPONENT SOLID PHASES CONTAINING AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT
#9High aspect ratio layered double hydroxide materials and methods for preparation thereof
#10Resist composition, method of forming resist pattern, acid generator, photoreactive quencher, and compound
#11Chemically-amplified positive resist composition and resist patterning process using the same
#12Multiple-component solid phases containing at least one active pharmaceutical ingredient
#13Tricyclodecane monomethanol monocarboxylic acid and derivatives thereof
#14Photoresist composition
#15Method for producing substituted diamantanes
#16Microporous catalyst and method for hydrogenating aromatic compounds
#17Pharmaceutical co-crystal compositions
#18Adamantanetricarboxylic acid derivatives
#19Novel olanzapine forms and related methods of treatment
#20Production of carboxylic acids or carboxylic acid esters
#21Method for the use of [11C] carbon monoxide in labeling synthesis of 11C-labelled acids by photo-induced free radical carbonylation
#22Microporous catalyst and method for hydrogenating aromatic compounds
#23Production process for high purity tricyclo-[5.2.1.0]decane-2-carboxylic acid ester